A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting
出版年份 2021 全文链接
标题
A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting
作者
关键词
-
出版物
Science Advances
Volume 7, Issue 6, Pages eaba0776
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-02-09
DOI
10.1126/sciadv.aba0776
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Nanostrategy for Efficient Imaging‐Guided Antitumor Therapy through a Stimuli‐Responsive Branched Polymeric Prodrug
- (2020) Hao Cai et al. Advanced Science
- Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
- (2020) Wenqi Yu et al. ACS Central Science
- Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer
- (2020) Rui Liu et al. JOURNAL OF CONTROLLED RELEASE
- Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites
- (2020) Jun Cao et al. ADVANCED DRUG DELIVERY REVIEWS
- A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis
- (2020) Lin Qin et al. Science Advances
- Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
- (2019) Michael Shafique et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Tumor Microenvironment‐Responsive Dual Drug Dimer‐Loaded PEGylated Bilirubin Nanoparticles for Improved Drug Delivery and Enhanced Immune‐Chemotherapy of Breast Cancer
- (2019) Xiaotong Yang et al. ADVANCED FUNCTIONAL MATERIALS
- Development and application of hyaluronic acid in tumor targeting drug delivery
- (2019) Zhijian Luo et al. Acta Pharmaceutica Sinica B
- Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis
- (2018) Rui Liu et al. JOURNAL OF CONTROLLED RELEASE
- High Drug Loading and Sub-Quantitative Loading Efficiency of Polymeric Micelles Driven by Donor–Receptor Coordination Interactions
- (2018) Shixian Lv et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Environment-stimulated nanocarriers enabling multi-active sites for high drug encapsulation as an “on demand” drug release system
- (2018) F. R. Cheng et al. Journal of Materials Chemistry B
- Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy
- (2018) Bong Geun Cha et al. ACS Central Science
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- Satb1: Restraining PD1 and T Cell Exhaustion
- (2017) Briana G. Nixon et al. IMMUNITY
- Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
- (2017) Yuchen Fan et al. NANO LETTERS
- Redox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy
- (2017) Wei Zhou et al. Nanoscale
- Tumor-Specific Multiple Stimuli-Activated Dendrimeric Nanoassemblies with Metabolic Blockade Surmount Chemotherapy Resistance
- (2016) Yachao Li et al. ACS Nano
- Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
- (2016) Giuseppa Pistritto et al. Aging-US
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
- (2015) Kathleen M. Mahoney et al. CLINICAL THERAPEUTICS
- Dimeric Drug Polymeric Nanoparticles with Exceptionally High Drug Loading and Quantitative Loading Efficiency
- (2015) Kaimin Cai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Doxorubicin, DNA torsion, and chromatin dynamics
- (2013) Fan Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells
- (2011) Liang Zhang et al. BIOMATERIALS
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- Cancer nanotechnology: application of nanotechnology in cancer therapy
- (2010) Ranjita Misra et al. DRUG DISCOVERY TODAY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now